Home › Trial NCT00005081
Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma
- Trial IDNCT00005081
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorDuke University
- Enrollment—
- Start date2000-08
- ConditionsBrain and Central Nervous System Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.